With Pradaxa On The Rise, Medco Gathers Evidence On Warfarin Diagnostic Testing

Pharmacy benefits management company Medco Health Solutions Inc. says that with the newly approved oral anticoagulant Pradaxa (dabigatran) off to a good commercial start, it plans to monitor outcomes and compare results with generic warfarin that has been optimized according to genetic testing.

More from Archive

More from Pink Sheet